Neurocrine Bioscience buy Piper Sandler
Start price
06.05.25
/
50%
€105.90
Target price
06.05.26
€136.35
Performance (%)
6.94%
Price
26.01.26
€113.25
Summary
This prediction is currently active. The BUY prediction by Piper_Sandler shows slight gains of 6.94%. This prediction currently runs until 06.05.26. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 0.399% | 0.399% |
| iShares Core DAX® | -0.121% | 2.507% |
| iShares Nasdaq 100 | 0.081% | -0.241% |
| iShares Nikkei 225® | -1.748% | 4.105% |
| iShares S&P 500 | -0.961% | -0.143% |
Comments by Piper_Sandler for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) had its "overweight" rating re-affirmed by analysts at Piper Sandler. They now have a $154.00 price target on the stock, down previously from $160.00.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Piper_Sandler for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.85
29.10.25
29.10.25
€153.67
29.10.26
29.10.26
-3.90%
26.01.26
26.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€115.25
31.07.25
31.07.25
€153.09
31.07.26
31.07.26
-1.74%
26.01.26
26.01.26
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€130.60
23.12.24
23.12.24
€153.97
23.12.25
23.12.25
-6.36%
24.12.25
24.12.25